-+ 0.00%
-+ 0.00%
-+ 0.00%

SAB Biotherapeutics Inc. Files Prospectus for $175 Million Oversubscribed Private Placement to Fund Autoimmune T1D Study

Reuters·07/21/2025 11:32:02

Please log in to view news